Clinical Trials Logo
  1. Home
  2. Heart Failure, Congestive
  3. NCT00494117
  4. Details
NCT00494117 Clinical Trial

Investigation of Heart Failure Status Over Time Using Respiratory Parameters

Heart Failure, Congestive Clinical Trial

Official title:
Investigation of Heart Failure Status Over Time Using Respiratory Parameters

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00494117
Other study ID # X07- 0052
Secondary ID
Status Completed
Phase N/A
First received June 28, 2007
Last updated July 25, 2010
Start date June 2007
Est. completion date March 2010

Study information
Verified date July 2010
Source ResMed
Contact n/a
Is FDA regulated No
Health authority Australia: Department of Health and Ageing Therapeutic Goods Administration
Study type Observational

Clinical Trial Summary

The purpose of the study is to investigate respiratory indicators for clinically important changes in Heart Failure status over time.

Recruitment information / eligibility
Status Completed
Enrollment 50
Est. completion date March 2010
Est. primary completion date March 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Moderate to severe Heart Failure (as determined by Echocardiogram or by treating physician)

Exclusion Criteria:

- Malignant disease affecting gas exchange or respiratory parameters

- Medications compromising breathing with no adverse affects on heart failure

- Clinically significant (moderate to severe) asthma requiring therapy

- Chronic parenchymal lung disease (FEV1/FVC ratio = 65% or as determined by the treating physician)

- Severe pulmonary hypertension

- Heart failure due to alcohol abuse or chemotherapy

- Narcotic abuse/intravenous drug use (including HIV+ and hepatitis C)

- Alcohol consumption > 80g/day

- Patients receiving home Oxygen

- Methicillin- resistant Staphylococcus aureus infection

- Narcolepsy

- Cataplexy

- Enrolled in any concurrent study, that may confound the results of this study.

- Inability or refusal to sign the Patient Consent Form

- Inability or refusal to adhere to protocol requirements

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Device:
• ApneaLink
A two channel sleep screening device for the assessment of Sleep Disordered Breathing.

Locations
Country Name City State
Australia Royal Prince Alfred Hospital Camperdown New South Wales

Sponsors (1)
Lead Sponsor Collaborator
ResMed

Country where clinical trial is conducted

Australia, 

See also
  Status Clinical Trial Phase
Completed NCT01357850 - A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure Phase 2
Recruiting NCT00532688 - N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure Phase 2/Phase 3
Terminated NCT00383630 - Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure Phase 2
Completed NCT00531661 - CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients N/A
Completed NCT00159614 - Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment Phase 2
Terminated NCT00125437 - Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy N/A
Completed NCT00149435 - Cardiovascular Health Study (CHS) Events Follow-up Study
Completed NCT00241761 - Epidemiology of Depression and Heart Failure in Aging N/A
Completed NCT00094263 - Long-Term Predictors of Morbidity in Older Age N/A
Terminated NCT00357591 - Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation N/A
Completed NCT00202579 - Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure Phase 2
Completed NCT00048425 - Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. Phase 3
Completed NCT00530426 - Heart Failure Registry Phase 4
Completed NCT00023556 - Genetic Architecture of Heart Disease in Rural Brazil N/A
Terminated NCT00190359 - Growth Hormone and Heart Failure N/A
Completed NCT00004562 - Occluded Artery Trial (OAT) Phase 3
Completed NCT00005265 - Natural History of Coronary Heart Disease N/A
Completed NCT02772068 - Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a Early Phase 1
Completed NCT02925546 - A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets Phase 1
Completed NCT01074307 - A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea Phase 4